Vancomycin use in pediatric neurosurgery patients

American Journal of Infection Control

Volumn 27, Issue 6, 1999, Pages 482-487

  Shah, Samir S ^b   Sinkowitz Cochran, Ronda L ^a   Keyserling, Harry L ^b   Jarvis, William R ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DRUG INDICATION; DRUG USE; FEMALE; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUROSURGERY; PEDIATRICS; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE;

EID: 0032786502     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(99)70025-8     Document Type: Article

References (33)

1. 1. Livornese LL Jr, Dias S, Samel C, Romanowski B, Taylor S, May P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
2. 2. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-5.
3. 3. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-5.
4. 4. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
5. 5. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, et al. Outbreak of vancomycin-, ampicillin-, and amino-glycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363-7.
6. 6. Boyle JF, Soumakis SA, Rendo A, Herrington JA, Gianarkis DG, Thurberg GE, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-5.
7. 7. Goldmann DA. Vancomycin-resistant Enterococcus faecium: headline news. Infect Control Hosp Epidemiol 1992;13:695-9.
8. 8. Leclercq R, Derlot E, Weber M, Duval J, Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1989;33:10-5.
9. 9. Uttley AH, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989;103:173-81.
10. 10. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;72:195-8.
11. 11. Sinkowitz RL, Keyserling H, Walker TJ, Holland J, Jarvis WR. Epidemiology of vancomycin usage at a children's hospital, 1993 through 1995. Pediatr Infect Dis J 1997;16:485-9.
12. 12. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-13.
13. 13. Dean AG, Dean JA, Coulombier D, et al. Epi-Info version 6: a word processing, database, and statistics program for epidemiology on microcomputer. Atlanta: Center for Disease Control and Prevention, 1994.
14. 14. Bingen E, Lambert-Zechovsky N, Mariani-Kurkdjian P, Cezard J, Navarro J. Bacteremia caused by a vancomycin-resistant enterococcus. Pediatr Infect Dis J 1989;8:475-6.
15. 15. Bingen E, Denamur E, Lambert-Zechovsky N, Elion J. Evidence for the genetic unrelatedncss of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol 1991;29:1888-92.
16. 16. Livingston RA, Froggatt JW, McLaughlin JM, Dick JD. Vancomycin-resistant enterococci: infection and colonization within a children's center. Pediatr Res 1991;29:178A.
17. 17. Moellering RC Jr. The Garrod lecture. The Enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 1991;28:1-12.
18. 18. Centers for Disease Control and Prevention. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR Morb Mortal Wkly Rep 1997;46:624-6.
19. 19. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR Morb Mortal Wkly Rep 1997;46:765-6.
20. 20. Poyart C, Pieire C, Quesne G, Pron B, Berche P, Trieu-Cuot P. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 1997;41:24-9.
21. 21. Anglim AM, Klym B, Byers KE, Scheld WM, Farr BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med 1997;157:1132-6.
22. 22. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA 1993;269:598-602.
23. 23. Evans ME, Kortas KJ. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol 1996;17:356-9.
24. 24. Kim YS, Pons VG. Infections in the neurosurgical intensive care unit. Neurosurg Clin North Am 1994;5:741-54.
25. 25. Dempsey R, Rapp RP, Young B, Johnston S, Tibbs P. Prophylactic parenteral antibiotics in clean neurosurgical procedures: a review. J Neurosurg 1988;69:52-7.
26. 26. Haines SJ. Efficacy of antibiotic prophylaxis in clean neurosurgical operations. Neurosurgery 1989;24:401-5.
27. 27. Shapiro M. Prophylaxis in otolaryngologic surgery and neurosurgery: a critical review. Rev Infect Dis 1991;13(Suppl 10):S858-68.
28. 28. Haines SJ, Walters BC. Antibiotic prophylaxis for cerebrospinal fluid shunts: a meta-analysis. Neurosurgery 1994;34:87-92.
29. 29. Zentner J, Gilsbach J, Felder T. Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 129 patients. Neurosurg Rev 1995;18:169-72.
30. 30. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, et al. Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: a randomized, prospective, blinded clinical study. Neurosurgery 1993;33:416-22.
31. 31. Geraghty J, Feely M. Antibiotic prophylaxis in neurosurgery: a randomized controlled trial. J Neurosurg 1984;60:724-6.
32. 32. DiPiro JT, Cheung RP, Bowden TA Jr, Mansberger JA. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986;152:552-9.
33. 33. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992;326:281-6.